Skip to main content

Table 1 The demographic and clinical characteristics of study participants

From: Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment

Group

ATB

LTBI (n = 10)

HC (n = 10)

Total (n = 24)

PTB (n = 14)

TBP (n = 10)

Age, median (IQR)

40.5 (37)

35 (29.25)

49 (49)

50.5 (32.75)

43.5 (26)

Male, n (%)

18 (75)

9 (64.3)

9 (90)

3 (30)

1 (10)

BCG vaccination, n (%)

18 (75)

10 (71.4)

8 (80)

8 (80)

9 (90)

Culture positive, n (%)

11 (45.8)

6 (42.9)

5 (50)

Xpert MTB/RIF positive, n (%)

4 (16.7)

3 (21.4)

1 (10)

Confirmed TB by pathology, n (%)

2 (8.3)

2 (20)

Co-morbidity, n (%)

     

 Diabetes

1 (4.2)

1 (10)

 Hypertension

3 (12.5)

2 (14.3)

1 (10)

 Arrhythmia

1 (4.2)

1 (7.1)

  1. ATB active tuberculosis, PTB pulmonary tuberculosis, TBP tuberculous pleurisy, LTBI latent tuberculosis infection, HC healthy controls, BCG bacillus Calmette-Guerin, TB tuberculosis